Acute effects of haloperidol on cerebral cortex blood flow in normal and schizophrenic subjects

Biological Psychiatry

Volumn 40, Issue 7, 1996, Pages 604-608

  Goldman, Ron G ^a   Alexander, Gene E ^a   Zemishlany, Zvi ^a   Mukherjee, Sukdeb ^a   Sackeim, Harold ^a   Prohovnik, Isak ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

brain imaging; cerebral blood flow; haloperidol neuroleptics; rCBF; schizophrenia

Indexed keywords

HALOPERIDOL;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030272956     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00391-6     Document Type: Article

References (18)

1. Bartlett EJ, Wolkin A, Brodie JD, Laska EM, Wolf AP, Sanfilipo M (1991): Importance of pharmacologic control in PET studies: Effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia. Psychiatry Res Neuroimag 40:115-124.
2. Bartlett EJ, Brodie JD, Simkowitz P, Dewey SL, Rusinek H, Wolf AP, Fowler JS, Volkow ND, Smith G, Wolkin A, Cancro R (1994): Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. Am J Psychiatry 151:681-686.
3. Buchsbaum MS, Potkin SG, Marshall JF, Lottenberg S, Teng C, Heh CW, Tafalla R, Reynolds C, Lennart A, Plon L, Bunney WE (1992): Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia. Neuropsychopharmacology 6:155-163.
4. Endicott J, Spitzer R (1978): A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 35:837-844.
5. Gur RE, Resnick SM, Gur RC, Alavi A, Caroff S, Kushner M, Reivich M (1987): Regional brain functioning in schizophrenia: II. Repeated evaluation with positron emission tomography. Arch Gen Psychiatry 44:126-129.
6. Jibiki I, Matsuda H, Yamaguchi N, Kurokawa K, Hisada K (1990-1991): Acutely administered haloperidol-induced widespread reduction of regional cerebral blood flow observed from subtraction of brain imaging with single photon emission computed tomography using technetium-99m hexamethyl-propylenamine oxime. Neuropsychobiology 24:125-128.
7. Kahn DA, Prohovnik I, Lucas LR, Sackeim HA (1989): Dissociated effects of amphetamine on arousal and cortical blood flow. Biol Psychiatry 25:755-767.
8. McCulloch J, Savaki H, Sokoloff L (1982): Distribution of effects of haloperidol on energy metabolism in the rat brain. Brain Res 243:81-90.
9. Miller AL, Maas JW, Contreras S, Seleshi E, True JE, Bowden C, Castiglioni J (1993): Acute effects of neuroleptics on unmedicated schizophrenic patients and controls. Biol Psychiatry 34:178-187.
10. Nillson A, Risberg J, Jahanson M, Gustafson L (1977): Regional changes of cerebral blood flow during haloperidol therapy in patients with paranoid symptoms. Acta Psychiat Scand 64(suppl):478-479.
11. Pizzolato G, Soncrant TT, Rapoport SI (1984); Haloperidol and cerebral metabolism in the conscious rat: Relation to pharmacokinetics. J Neurochem 43:724-732.
12. Prohovnik I (1988): Data quality, integrity, and interpretation. In Knezevic S, Maximilian VA, Mubrin Z, Prohovnik I, Wade J (eds), Handbook of Regional Cerebral Blood Flow. Hillsdale, NJ: Earlbaum, pp 37-50.
13. Prohovnik I, Knudsen E, Risberg J (1983): Accuracy of models and algorithms for determination of fast-compartment flow by non-invasive 133-Xe clearance. In Magistretti P (ed), Functional Radionuclide Imaging of the Brain. New York: Raven Press, pp 87-115.
14. Prohovnik I, Knudsen E, Risberg J (1985): Theoretical evaluation and simulation test of the initial slope index for noninvasive rCBF. In Hartman H, Hoyer S (eds), Cerebral Blood Flow and Metabolism Measurement. Berlin: Springer Verlag, pp 56-60.
15. Spitzer RL, Endicott J, Robins E (1978): Research diagnostic criteria: Rationale and reliability. Arch Gen Psychiatry 35: 773-782.
16. Volkow N, Brodie JD, Wolf AP, Angrist B, Russel J, Cancro R (1986): Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration. J Neurol Neurosurg Psychiatry 49:1199-1202.
17. Wik G, Wiesel FA, Sjogren I, Blomqvist G, Greitz T, Stone-Elander S (1989): Effects of sulpiride and chlorpromazine on regional glucose metabolism in schizophrenic patients as determined by positron emission tomography. Psychopharmacology 97:309-318.
18. Wolkin A, Jaeger J, Brodie JD, Wolf AP, Fowler J, Rotrosen J, Gomez-Mont F, Cancro R (1985): Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am J Psychiatry 142:564-571.